JumpStart^™ Taq DNA Polymerase

JumpStart^™ Taq DNA polymerase is a combination of Sigma′s high-performance Taq DNA Polymerase and JumpStart Taq antibody. The Taq DNA Polymerase activity is inactivated by combining the enzyme with JumpStart Taq antibody, a neutralizing monoclonal antibody to Taq DNA polymerase. Antibody inactivation provides a simple, efficient procedure for hot-start PCR. During PCR, JumpStart Taq DNA polymerase is inactive at low (room) temperature, as the temperature is raised above 70 °C in the first denaturation step of the cycling process, the complex dissociates, and the polymerase becomes fully active.

JumpStart^™ Taq DNA Polymerase has been used:

• in the amplification of DNA libraries of varying sizes
• in a methylation-specific, quantitative real-time polymerase chain reaction (MS-qPCR) to determine the BRCA1 promoter methylation status
• in the generation of plasmid by amplifying the full-length of HIF1β via PCR

JumpStart Taq DNA Polymerase is provided with a 10× reaction buffer available with and without MgCl_2. The magnesium free 10× buffer also includes a separate tube of 25 mM MgCl₂ for optimization.

Supplied with 10× reaction buffer containing 15 mM MgCl₂

Sigma′s JumpStart Taq DNA Polymerase is an antibody-inactivated hot-start enzyme designed to minimize non-specific amplification while increasing target yield. Once the reaction temperature reaches 70°C, Taq DNA polymerase activity is restored and the resulting PCR exhibits a higher specificity and yield. This antibody-enzyme complex allows for easy and convenient set-up with less contamination risk than manual hot-start techniques. The enzyme may also be included in the master mix preparation resulting in more consistency from one reaction to the next.

View more detailed information on JumpStart Taq enzymes at www.sigma-aldrich.com/hotstart.

One unit incorporates 10 nmol of total dNTPs into acid-precipitable DNA in 30 min at 74 °C.

Use of this product is covered by one or more of the following US patents and corresponding patent claims outside the US: US 8,404,464 and US 7,972,828. The purchase of this product includes a limited, non-transferable immunity from suit under the foregoing patent claims.

Antibody licensed for in vitro research use under U.S. Patent No. 5,338,671 and 5,587,287, and corresponding patents in other countries.

JumpStart is a trademark of Sigma-Aldrich Co. LLC